These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 6929626)

  • 1. [Urological complications in patients with multiple sclerosis (author's transl)].
    Kiesswetter H; Flamm J; Hennrich F; Summer K; Schober W
    Wien Klin Wochenschr; 1980 Jan; 92(1):16-22. PubMed ID: 6929626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bladder and sphincter disorders in multiple sclerosis. Clinical, urodynamic and neurophysiological study of 225 cases].
    Amarenco G; Kerdraon J; Denys P
    Rev Neurol (Paris); 1995 Dec; 151(12):722-30. PubMed ID: 8787103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urological problems in patients suffering from multiple sclerosis (author's transl)].
    Moriel EZ; Rabey JM; Farkas A; Steifler M; Firstater M
    Sem Hop; 1979 Dec 8-15; 55(41-42):1921-3. PubMed ID: 231314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of bladder dysfunction to lesion site in multiple sclerosis.
    Araki I; Matsui M; Ozawa K; Takeda M; Kuno S
    J Urol; 2003 Apr; 169(4):1384-7. PubMed ID: 12629367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vesico-sphincter dysfunction in 108 cases of multiple sclerosis].
    Bielsa Galí O; Arango Toro O; Pascual Calvet J; Cortadellas Angel R; Conde Santos G; Lorente Garín JA; Gelabert Mas A
    Arch Esp Urol; 2001 Sep; 54(7):697-701. PubMed ID: 11692434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urological treatment of patients with spinal cord injury in the chronic stage].
    Suemori T; Natsume O; Yamamoto M; Momose H; Okamura K; Shiomi T; Yamada K
    Hinyokika Kiyo; 1987 Jul; 33(7):1070-4. PubMed ID: 3687630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary dysfunction in multiple sclerosis.
    Nakipoglu GF; Kaya AZ; Orhan G; Tezen O; Tunc H; Ozgirgin N; Ak F
    J Clin Neurosci; 2009 Oct; 16(10):1321-4. PubMed ID: 19560927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation of urodynamic findings with cranial magnetic resonance imaging findings in multiple sclerosis.
    Kim YH; Goodman C; Omessi E; Rivera V; Kattan MW; Boone TB
    J Urol; 1998 Mar; 159(3):972-6. PubMed ID: 9474196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and management of the urologic consequences of neurologic disease.
    Kotkin L; Milam DF
    Tech Urol; 1996; 2(4):210-9. PubMed ID: 9085542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurogenic dysfunction of the bladder in disseminated sclerosis. A retrospective material].
    Hebjorn S
    Ugeskr Laeger; 1973 Oct; 135(43):2317-21. PubMed ID: 4775654
    [No Abstract]   [Full Text] [Related]  

  • 13. [Urination disorders in multiple sclerosis: value of urodynamic assessment].
    Gallien P; Le Bot-Le Borgne MP; Nicolas B; Robineau S; Toulouse P; Brissot R; Edan G
    J Urol (Paris); 1994; 100(6):294-8. PubMed ID: 7745258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical study of voiding status in multiple sclerosis patients].
    Komatsu K; Nagano K; Yokoyama O; Kawaguchi K; Hisazumi H; Hayashi S
    Hinyokika Kiyo; 1991 Jan; 37(1):25-9. PubMed ID: 2011964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia.
    Chartier-Kastler EJ; Ruud Bosch JL; Perrigot M; Chancellor MB; Richard F; Denys P
    J Urol; 2000 Nov; 164(5):1476-80. PubMed ID: 11025686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicourethral dysfunction associated with multiple sclerosis: clinical and urodynamic perspectives.
    Barbalias GA; Nikiforidis G; Liatsikos EN
    J Urol; 1998 Jul; 160(1):106-11. PubMed ID: 9628615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower urinary tract dysfunction in Machado-Joseph disease: a study of 11 clinical-urodynamic observations.
    Sakakibara R; Uchiyama T; Arai K; Yamanishi T; Hattori T
    J Neurol Sci; 2004 Mar; 218(1-2):67-72. PubMed ID: 14759635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunction of the detrusor and urethra in multiple sclerosis: the role of drug therapy.
    Awad SA; Wilson JW; Fenemore J; Kiruluta HG
    Can J Surg; 1982 May; 25(3):259-62. PubMed ID: 6123379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional voiding in children secondary to internal sphincter dyssynergia: treatment with phenoxybenzamine.
    Smey P; King LR; Firlit CF
    Urol Clin North Am; 1980 Jun; 7(2):337-47. PubMed ID: 7404872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Personal experiences with phenoxybenzamine (Dibenzyran) in the treatment of functional disorders of bladder emptying].
    Wehnert J; Sage S
    Z Urol Nephrol; 1988 Mar; 81(3):153-8. PubMed ID: 3388995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.